In the study of Ferroni and colleagues, breast cancer patients carrying HER2 tumors are reported with increased levels of urinary oxidative stress markers compared to both luminal and triple-negative patients, similarly, as the data reported here to LN− patients. Here, ERBB2 is linked to breast cancer.